
Water systems in pharmaceutical manufacturing processes for non-sterile, water-based drug products are vulnerable to water-borne pathogens. As a result, the Food and Drug Administration is urging manufacturers to adopt measures that both prevent water-borne contaminants from entering pharmaceutical production processes and detect them in drug product components and finished products. Last year, several manufacturers… Read more »